Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risk-Adjusted HSCT for Fanconi Anemia (RAFA)
NCT02143830Phase 2Recruiting
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Apr 2014
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of busulfan in Fanconi anemia (FA), sponsored by Cincinnati Children's Hospital Medical Center. Started Apr 2014; status: recruiting.
02
Drugs
busulfan
03
Conditions
Fanconi anemia (FA)
Beyond the preview
Go deeper on NCT02143830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02143830.